FDA Drug Application (009170) for MYSOLINE by VALEANT

Back to FDA Applications sponsored by VALEANT

Application Number009170
Product Number002
FormTABLET;ORAL
Dosage250MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMYSOLINE
Active IngredientPRIMIDONE

Active IngredientCount
List of drugs with Active Ingredient PRIMIDONE2


Back to FDA Applications sponsored by VALEANT